ARCHIVES

ODAC Votes For Approval Of PegIntron For Melanoma, Votrient For Renal Cancer

This article is from The Cancer Letter archive.

Vol. 35 No. 37 | October 9, 2009

Download PDF Visit The Full Archive

Related Articles

NCI Agrees To Offer New Screening RFP In The Future

May 28, 1976

In Brief: DOD Bill includes $135M For breast Cancer, $45M For prostate Cancer Technologies

October 3, 1997

U.S. Radiologists Criticize Canadian Study Of Mammography Screening Showing No Benefit

November 27, 1992

ASCO Teleconference Set For Nov. 12

October 31, 1986

ASCO Growth Changes, Prepare Society for ‘90s

June 8, 1990

Regorafenib Trial Meets Primary Endpoint; Overall Survival Improved by 29 Percent

January 27, 2012